Navigation Links
Constipation in Medical Technology
... 419 patients with irritable bowel syndrome with constipation (IBS-C). Previous analyses of these data ... of linaclotide in patients with IBS-C or chronic constipation (CC).
(Logo: ...
About Irritable Bowel Syndrome with constipation (IBS-C)
IBS-C is a chronic functional ...
... study of NKTR-118 in patients with opioid-induced constipation (OIC). NKTR-118, a peripheral opioid antagonist, ... which the patient had to demonstrate significant constipation in the absence of laxatives, to the change in ... abdominal cramping, and gastroesophageal reflux. constipation is the hallmark of this syndrome and is generally ...
... 20%, 29%; anorexia 19%, 27%; headache 19%, 23%; constipation 18%, 22%; with the following important adverse ... <1%, 2%; anorexia 1%, 1%; headache 2%, 4%; constipation 1%, 0%; convulsions 3%, 3%; thrombocytopenia 3%, ... 6%, 42%; headache 6%, 41%; fatigue 4%, 34%; constipation 1%, 33%; convulsions 5%, 23%; with the following ...
... The most common treatment-emergent AEs were constipation (64 percent), fatigue (60 percent) and nausea (52 ... weakness) (64%), nausea (55%), diarrhea (52%), constipation (41%), peripheral neuropathy NEC (including ... 5%), diarrhea (46% vs 17%), anemia (43% vs 55%), constipation (37% vs 16%), neuralgia (36% vs 1%), leukopenia ...
... nausea (31%), fatigue (28%), headache (31%), constipation (21%), diarrhea (22%) and vomiting (21%). The ... (>10%) were rash (28%), pruritus (20%) and constipation (18%). The most common (>10%) Grade 3/4 ... anemia (33%), pyrexia (32%), vomiting (32%), constipation (31%), dyspnea (27%), diarrhea (24%), weakness ...
... 420 patients with irritable bowel syndrome with constipation (IBS-C). Analysis of the data indicates that ... study showing improvement in abdominal pain and constipation are encouraging," said Douglas Drossman, M.D., ... patients diagnosed with IBS-C. About Chronic constipation (CC) As many as 26 million Americans suffer ...
... 419 patients with irritable bowel syndrome with constipation (IBS-C) in a plenary session at the American ... for its potential to treat IBS-C, chronic constipation (CC), and other gastrointestinal disorders. ... patients diagnosed with IBS-C. About Chronic constipation (CC) As many as 26 million Americans suffer ...
... none of the placebo-treated patients. "Chronic constipation is an uncomfortable condition that can ... with CC and irritable bowel syndrome with constipation (IBS-C). Ironwood and Forest previously announced ... and bloating on a daily basis, and constipation severity and overall relief ...
... overall symptoms of Irritable Bowel Syndrome with constipation (IBS-C). These results were presented at ... mcg dose for the treatment of Chronic Idiopathic constipation in adults. These data were among others presented ... About Irritable Bowel Syndrome with constipation (IBS-C) IBS is a disorder characterized by ...
... nausea and vomiting with short-term use, and constipation with longer, chronic use. Such symptoms can lead ... lower incidence of nausea, vomiting, constipation and composite nausea/vomiting (P<0.001) for all ... While the incidence of nausea, vomiting, constipation and the composite nausea and vomiting were ...
... abdominal cramping, and gastroesophageal reflux. constipation is the hallmark of this syndrome, and is ... opioids are likely to experience significant constipation and other symptoms of OBD. According to ... for moderate-to-severe pain revealed that constipation is one of the most common opioid-related side ...
... treatment being developed to treat opioid-induced constipation (OIC) and other clinical manifestations ... tolerability of NKTR-118 in patients experiencing constipation while receiving opioid therapy. "We are excited ... target peripheral opioid receptors to alleviate constipation associated with opioid therapy, while reducing ...
... dysfunction (OBD), including opioid-induced constipation (OIC). Data from a single-dose, ... abdominal cramping, and gastroesophageal reflux. constipation is the hallmark of this syndrome, and is ... opioids are likely to experience significant constipation and other symptoms of OBD. Currently, there are ...
... approved for the treatment of Chronic Idiopathic constipation in adults as AMITIZA(R) (24 mcg, oral gel ... lubiprostone can help many Americans who have constipation as a result of taking opioid-based drugs for ... conditions inclusive of severe constipation brought about by the use of narcotic medications ...
... fatigue, malaise and weakness) (64%), nausea (55%), diarrhea (52%), constipation (41%), peripheral neuropathy NEC (including peripheral sensory neuropathy ... neuropathy (47% vs 5%), diarrhea (46% vs 17%), anemia (43% vs 55%), constipation (37% vs 16%), neuralgia (36% vs 1%), leukopenia (33% vs 30%), vomiting ...
... rash (33%), pruritus (29%), nausea (31%), fatigue (28%), headache (31%), constipation (21%), diarrhea (22%), and vomiting (21%). The most common ( > 10%) ... adverse reactions ( > 10%) were rash (28%), pruritus (20%), and constipation (18%). The most common ( > 10%) Grade 3/4 adverse reactions were ...
... fatigue, malaise and weakness) (64%), nausea (55%), diarrhea (52%), constipation (41%), peripheral neuropathy NEC (including peripheral sensory neuropathy ... neuropathy (47% vs 5%), diarrhea (46% vs 17%), anemia (43% vs 55%), constipation (37% vs 16%), neuralgia (36% vs 1%), leukopenia (33% vs 30%), vomiting ...
... side effects that occurred greater than placebo (a "sugar" pill) were constipation (11.0% vs. 7.0%), indigestion (8.3% vs. 3.5%), nausea (4.2% vs. 3.9%), ... with type 2 diabetes side effects that occurred greater than placebo were constipation (8.7% vs. 2.0%), inflamed nasal passages and throat (4.1% vs. 3.6%), ...
... compound currently being evaluated for the treatment of IBS-C, chronic constipation (CC), and other gastrointestinal disorders. Linaclotide was designed to ... treat the nine million U.S. patients diagnosed with IBS-C. About Chronic constipation (CC) As many as 26 million Americans suffer from CC. Patients with CC ...
... neuropathy (47% vs 5%), diarrhea (46% vs 17%), anemia (43% vs 55%), constipation (37% vs 16%), neuralgia (36% vs 1%), leukopenia (33% vs 30%), vomiting ... fatigue, malaise and weakness) (64%), nausea (55%), diarrhea (52%), constipation (41%), peripheral neuropathy NEC (including peripheral sensory neuropathy ...
... bromide) for the treatment of opioid-induced side effects, including constipation (subcutaneous and oral formulations) and post-operative ileus (intravenous ... subcutaneous injection is indicated for the treatment of opioid-induced constipation (OIC) in patients with advanced illness who are receiving palliative care, ...
... trial, approximately 33 percent were characterized as D-IBS, 37 percent constipation predominant (C-IBS) and 31 percent alternating between diarrhea and constipation (A-IBS). -- In the overall patient group, patients with at least ...
... rash (33%), pruritus (29%), nausea (31%), fatigue (28%), headache (31%), constipation (21%), diarrhea (22%), and vomiting (21%). The most common ( >10%) Grade ... reported adverse reactions ( >10%) were rash (28%), pruritus (20%), and constipation (18%). The most common ( >10%) Grade 3/4 adverse reactions were ...
... were somnolence (34% vs 9%), dry mouth (19% vs 3%), asthenia (10% vs 4%), constipation (10% vs 5%), abdominal pain (7% vs 3%), postural hypotension (7% vs 2%), ... placebo in clinical trials for schizophrenia were dry mouth (12% vs 1%), constipation (6% vs 5%), dyspepsia (5% vs 2%), sedation (13% vs 7%), somnolence (12% vs ...
... (89 percent), anemia (82 percent), pyrexia (53 percent), fatigue (48 percent), nausea (42 percent), cough (40 percent), petechiae (39 percent), constipation (35 percent), and diarrhea (34 percent). Please visit www.dacogen.com for full prescribing information. About Eisai Corporation of ...
... frequency greater than or equal to 10% among lurasidone subjects) for lurasidone versus placebo were nausea (16% vs. 3%), headache (11.1% vs. 10%), constipation (11.1% vs. 5.6%), vomiting (11.1% vs. 5.6%), dyspepsia (11.1% vs. 3.3%), somnolence (11.1% vs. 3.3%), insomnia (10.0% vs. 3.3%) and sedation (10.0% ...
... 2 clinical studies. Carfilzomib was generally well tolerated. The most common adverse events include fatigue headache, nausea, diarrhea, constipation and anemia. Notably, there were no incidents of Grade 3/4 neuropathy, a common side effect associated with the approved proteasome inhibitor, ...
Ironwood Announces Linaclotide European Licensing Agreement with Almirall
... the treatment of irritable bowel syndrome with constipation (IBS-C) and other gastrointestinal conditions. ... for the treatment of IBS-C and chronic constipation (CC). Linaclotide demonstrated proof of concept ... period. In patients with CC, linaclotide reduced constipation throughout the 4-week treatment period. In both ...... study of NKTR-118 in patients with opioid-induced constipation (OIC). NKTR-118, a peripheral opioid antagonist, ... which the patient had to demonstrate significant constipation in the absence of laxatives, to the change in ... abdominal cramping, and gastroesophageal reflux. constipation is the hallmark of this syndrome and is generally ...
... 20%, 29%; anorexia 19%, 27%; headache 19%, 23%; constipation 18%, 22%; with the following important adverse ... <1%, 2%; anorexia 1%, 1%; headache 2%, 4%; constipation 1%, 0%; convulsions 3%, 3%; thrombocytopenia 3%, ... 6%, 42%; headache 6%, 41%; fatigue 4%, 34%; constipation 1%, 33%; convulsions 5%, 23%; with the following ...
... The most common treatment-emergent AEs were constipation (64 percent), fatigue (60 percent) and nausea (52 ... weakness) (64%), nausea (55%), diarrhea (52%), constipation (41%), peripheral neuropathy NEC (including ... 5%), diarrhea (46% vs 17%), anemia (43% vs 55%), constipation (37% vs 16%), neuralgia (36% vs 1%), leukopenia ...
... nausea (31%), fatigue (28%), headache (31%), constipation (21%), diarrhea (22%) and vomiting (21%). The ... (>10%) were rash (28%), pruritus (20%) and constipation (18%). The most common (>10%) Grade 3/4 ... anemia (33%), pyrexia (32%), vomiting (32%), constipation (31%), dyspnea (27%), diarrhea (24%), weakness ...
... 420 patients with irritable bowel syndrome with constipation (IBS-C). Analysis of the data indicates that ... study showing improvement in abdominal pain and constipation are encouraging," said Douglas Drossman, M.D., ... patients diagnosed with IBS-C. About Chronic constipation (CC) As many as 26 million Americans suffer ...
Ironwood Raises $50 Million to Advance Linaclotide Through Phase 3
... the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation (CC), to invest in a growing pipeline of ... linaclotide reduced abdominal pain and relieved constipation -- the hallmarks of the condition -- throughout ...... 419 patients with irritable bowel syndrome with constipation (IBS-C) in a plenary session at the American ... for its potential to treat IBS-C, chronic constipation (CC), and other gastrointestinal disorders. ... patients diagnosed with IBS-C. About Chronic constipation (CC) As many as 26 million Americans suffer ...
New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study
... therapy for the treatment of opioid-induced constipation (OIC) in patients with advanced illness who are ... to manage their pain, and experts say that constipation occurs in practically all of them. However, for ... United States for the treatment of opioid-induced constipation in patients with advanced illness who ...... none of the placebo-treated patients. "Chronic constipation is an uncomfortable condition that can ... with CC and irritable bowel syndrome with constipation (IBS-C). Ironwood and Forest previously announced ... and bloating on a daily basis, and constipation severity and overall relief ...
... overall symptoms of Irritable Bowel Syndrome with constipation (IBS-C). These results were presented at ... mcg dose for the treatment of Chronic Idiopathic constipation in adults. These data were among others presented ... About Irritable Bowel Syndrome with constipation (IBS-C) IBS is a disorder characterized by ...
... nausea and vomiting with short-term use, and constipation with longer, chronic use. Such symptoms can lead ... lower incidence of nausea, vomiting, constipation and composite nausea/vomiting (P<0.001) for all ... While the incidence of nausea, vomiting, constipation and the composite nausea and vomiting were ...
... abdominal cramping, and gastroesophageal reflux. constipation is the hallmark of this syndrome, and is ... opioids are likely to experience significant constipation and other symptoms of OBD. According to ... for moderate-to-severe pain revealed that constipation is one of the most common opioid-related side ...
Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2b Studies
... - Chronic constipation and IBS-C studies each meet primary endpoint - ... effects of linaclotide in patients with chronic constipation (CC), while the second study examined its effects ... and constipation severity and overall relief of constipation on a weekly basis. In addition, the use of rescue ...Oxygen Relieves IBS and Constipation Symptoms in New Clinical Studies
... is extremely successful at relieving symptoms of constipation and Irritable Bowel Syndrome. In fact, the ... standard for patients seeking relief for their constipation and IBS symptoms. Dr. Edward Group III, the ... to help millions of people suffering from constipation and IBS symptoms, he added, "The results were ...... treatment being developed to treat opioid-induced constipation (OIC) and other clinical manifestations ... tolerability of NKTR-118 in patients experiencing constipation while receiving opioid therapy. "We are excited ... target peripheral opioid receptors to alleviate constipation associated with opioid therapy, while reducing ...
... dysfunction (OBD), including opioid-induced constipation (OIC). Data from a single-dose, ... abdominal cramping, and gastroesophageal reflux. constipation is the hallmark of this syndrome, and is ... opioids are likely to experience significant constipation and other symptoms of OBD. Currently, there are ...
... approved for the treatment of Chronic Idiopathic constipation in adults as AMITIZA(R) (24 mcg, oral gel ... lubiprostone can help many Americans who have constipation as a result of taking opioid-based drugs for ... conditions inclusive of severe constipation brought about by the use of narcotic medications ...
New Data Suggest Cymbalta(R) Reduced Pain in Fibromyalgia Patients With and Without Depression
... include: -- For MDD: Nausea, dry mouth and constipation -- For DPNP: Nausea, somnolence (sleepiness), dizziness and constipation -- For GAD: Nausea, fatigue, dry mouth, somnolence (sleepiness) and constipation This is not a complete list of side effects. ...... fatigue, malaise and weakness) (64%), nausea (55%), diarrhea (52%), constipation (41%), peripheral neuropathy NEC (including peripheral sensory neuropathy ... neuropathy (47% vs 5%), diarrhea (46% vs 17%), anemia (43% vs 55%), constipation (37% vs 16%), neuralgia (36% vs 1%), leukopenia (33% vs 30%), vomiting ...
... rash (33%), pruritus (29%), nausea (31%), fatigue (28%), headache (31%), constipation (21%), diarrhea (22%), and vomiting (21%). The most common ( > 10%) ... adverse reactions ( > 10%) were rash (28%), pruritus (20%), and constipation (18%). The most common ( > 10%) Grade 3/4 adverse reactions were ...
... fatigue, malaise and weakness) (64%), nausea (55%), diarrhea (52%), constipation (41%), peripheral neuropathy NEC (including peripheral sensory neuropathy ... neuropathy (47% vs 5%), diarrhea (46% vs 17%), anemia (43% vs 55%), constipation (37% vs 16%), neuralgia (36% vs 1%), leukopenia (33% vs 30%), vomiting ...
... side effects that occurred greater than placebo (a "sugar" pill) were constipation (11.0% vs. 7.0%), indigestion (8.3% vs. 3.5%), nausea (4.2% vs. 3.9%), ... with type 2 diabetes side effects that occurred greater than placebo were constipation (8.7% vs. 2.0%), inflamed nasal passages and throat (4.1% vs. 3.6%), ...
... compound currently being evaluated for the treatment of IBS-C, chronic constipation (CC), and other gastrointestinal disorders. Linaclotide was designed to ... treat the nine million U.S. patients diagnosed with IBS-C. About Chronic constipation (CC) As many as 26 million Americans suffer from CC. Patients with CC ...
... neuropathy (47% vs 5%), diarrhea (46% vs 17%), anemia (43% vs 55%), constipation (37% vs 16%), neuralgia (36% vs 1%), leukopenia (33% vs 30%), vomiting ... fatigue, malaise and weakness) (64%), nausea (55%), diarrhea (52%), constipation (41%), peripheral neuropathy NEC (including peripheral sensory neuropathy ...
... bromide) for the treatment of opioid-induced side effects, including constipation (subcutaneous and oral formulations) and post-operative ileus (intravenous ... subcutaneous injection is indicated for the treatment of opioid-induced constipation (OIC) in patients with advanced illness who are receiving palliative care, ...
... trial, approximately 33 percent were characterized as D-IBS, 37 percent constipation predominant (C-IBS) and 31 percent alternating between diarrhea and constipation (A-IBS). -- In the overall patient group, patients with at least ...
Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting
... The most common adverse reactions related to Aloxi were headache (9%) and constipation (5%). Aloxi is contraindicated in patients known to have hypersensitivity ... pyrexia (53%), fatigue (48%), nausea (42%), cough (40%), petechiae (39%), constipation (35%), and diarrhea (34%). Please visit http://www.mgipharma.com or ...... rash (33%), pruritus (29%), nausea (31%), fatigue (28%), headache (31%), constipation (21%), diarrhea (22%), and vomiting (21%). The most common ( >10%) Grade ... reported adverse reactions ( >10%) were rash (28%), pruritus (20%), and constipation (18%). The most common ( >10%) Grade 3/4 adverse reactions were ...
Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials
... for the treatment of opioid-induced side effects, including constipation (oral and subcutaneous formulations) and post-operative ileus (intravenous ... formulation of methylnaltrexone for patients suffering from opioid-induced constipation while receiving palliative care, followed in May 2007 by Wyeth's ...... were somnolence (34% vs 9%), dry mouth (19% vs 3%), asthenia (10% vs 4%), constipation (10% vs 5%), abdominal pain (7% vs 3%), postural hypotension (7% vs 2%), ... placebo in clinical trials for schizophrenia were dry mouth (12% vs 1%), constipation (6% vs 5%), dyspepsia (5% vs 2%), sedation (13% vs 7%), somnolence (12% vs ...
Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting
... nausea (48% vs 40%), diarrhea (46% vs 39%), vomiting (32% vs 22%), constipation (31% vs 31%), mucositis/stomatitis (20% vs 5%), peripheral neuropathy ... events were asthenic conditions (64%), nausea (55%), diarrhea (52%), constipation (41%), peripheral neuropathy (39%), thrombocytopenia (36%), appetite ...SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia
... were somnolence (34% vs 9%), dry mouth (19% vs 3%), asthenia (10% vs 4%), constipation (10% vs 5%), abdominal pain (7% vs 3%), postural hypotension (7% vs 2%), ... placebo in clinical trials for schizophrenia were dry mouth (12% vs 1%), constipation (6% vs 5%), dyspepsia (5% vs 2%), sedation (13% vs 7%), somnolence (12% vs ...Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes
... fatigue (80%); thrombosis/embolism (7%); nausea (84%); vomiting (58%); constipation (44%); anorexia (35%); stomatitis/pharyngitis (28%); diarrhea (26%); ... events (all grades) were fatigue (87%); anorexia (62%); nausea (39%); constipation (30%); vomiting (25%); diarrhea (21%); stomatitis/pharyngitis (20%); ...ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study
... (72%/71%), dysphagia (65%/63%), asthenia (56%/49%), nausea (49%/37%), constipation (35%/30%) and vomiting (29%/23%). The most common adverse events seen in ... (55%/29%), abdominal pain (45%/26%), vomiting (41%/25%), fever (34%/27%), constipation (30%/26%), and headache (14%/26%). About ImClone Systems ImClone Systems ...Nektar Therapeutics Reports Second Quarter 2009 Financial Results
... across the blood-brain barrier, an important potential advance for small molecule therapies. The product is being developed to treat opioid-induced constipation (OIC). NKTR-102, PEGylated irinotecan, is currently in Phase 2 clinical studies in ovarian, breast and colorectal cancer. NKTR-105, PEGylated ...... (89 percent), anemia (82 percent), pyrexia (53 percent), fatigue (48 percent), nausea (42 percent), cough (40 percent), petechiae (39 percent), constipation (35 percent), and diarrhea (34 percent). Please visit www.dacogen.com for full prescribing information. About Eisai Corporation of ...
... frequency greater than or equal to 10% among lurasidone subjects) for lurasidone versus placebo were nausea (16% vs. 3%), headache (11.1% vs. 10%), constipation (11.1% vs. 5.6%), vomiting (11.1% vs. 5.6%), dyspepsia (11.1% vs. 3.3%), somnolence (11.1% vs. 3.3%), insomnia (10.0% vs. 3.3%) and sedation (10.0% ...
... 2 clinical studies. Carfilzomib was generally well tolerated. The most common adverse events include fatigue headache, nausea, diarrhea, constipation and anemia. Notably, there were no incidents of Grade 3/4 neuropathy, a common side effect associated with the approved proteasome inhibitor, ...
Other ContentsOther Tags
(Date:5/23/2013)... the team reveal the interplay of brain chemicals which ... Wellcome Trust and BBSRC. , By changing the ... perceptual abilities. While these changes can affect the strength ... fidelity of that response. , Lead author ... communicate with others, you can make yourself better heard ...
(Date:5/23/2013)... Wis. In an age when microbial pathogens are ... tamp down infection, a team of Wisconsin scientists has ... curbing the bacteria that cause staph infections. , Writing ... Society , a group led by University of Wisconsin-Madison ... with the "quorum sensing" behavior of Staphylococcus aureus ...
(Date:5/22/2013)... U.S. Forest Service scientists are part of "Landscapes ... the TKF Foundation, will examine how collaborative planning and ... from tragedy. , The TKF Foundation announced today that ... for grant funding. In addition to research on the ... and resiliency, the 3-year, $585,000 grant will contribute to ...
Breaking Biology News(10 mins):University of Wisconsin chemists find new compounds to curb staph infection 2'Landscapes of Resilience' to study how people use nature as a source of recovery 2(Date:5/23/2013)... May 23, 2013 Fresh Healthy Vending ... machines stocked with healthy food and drinks in locations ... company’s in-house, full-service marketing and advertising department has a ... the media for their franchisees, and to promote the ... been featured in many leading publications and TV networks ...
(Date:5/23/2013)... Lake City, Utah (PRWEB) May 23, 2013 ... Chevreau, PhD, R.D., published an article today on Tatalou.com ... an illness-free vacation. , The article, titled “ How ... why it’s important to carry hand sanitizer, when it’s ... to watch out for seafood, the importance of staying ...
(Date:5/23/2013)... Washington, DC (PRWEB) May 23, 2013 Teen ... through 2011, according to new data released today ... that time, the teen birth rate dropped at least 15% ... states. , There were also dramatic declines among all ... , Birth rates declined 40% or more for ...
(Date:5/23/2013)... MA (PRWEB) May 23, 2013 ... (BI) solutions, announced today that Paul ... Insight, will speak at the 2013 International Medical ... titled, “Unlock Expense & Revenue Visibility from Your ... Wednesday, May 29 from 2:30-3:25 p.m. in Azalea ...
(Date:5/23/2013)... May 23, 2013 Jim Fitzpatrick just ... Fitzpatrick Advertising developed yet another outside-of-the-box approach to reaching ... News.com, he brings daily newscasts to the retail automotive ... delivery of a broadcast news format. , CBTNews.com ... automotive news. Co-anchors Bridget Everett and Russell Brown host ...
Breaking Medicine News(10 mins):Health News:Fresh Healthy Vending Receives Recent National and Local Media Focus 2Health News:How to Stay Healthy While Traveling 2Health News:Dimensional Insight to Demonstrate How Hospitals Can Use Business Intelligence within MEDITECH Environments at 2013 International MUSE Conference 2Health News:Fitzpatrick Advertising Founder Brings Auto Industry into Focus with CBT News 2[0] Fresh Healthy Vending Receives Recent National and Local Media Focus[0] How to Stay Healthy While Traveling[0] New State Teen Birth Data Released; Declines in 48 States from 2007 through 2011 - A Statement from the National Campaign to Prevent Teen and Unplanned Pregnancy[0] Dimensional Insight to Demonstrate How Hospitals Can Use Business Intelligence within MEDITECH Environments at 2013 International MUSE Conference[0] Fitzpatrick Advertising Founder Brings Auto Industry into Focus with CBT News
ConjFoeresterLaguaEchartComforterIrrigatorNotchedtrephinesStilettoFlattenedDepresserZavaliaDepressorThimble
Other Tags| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |